This multi-disciplinary approach to immunotherapy serves as a useful survey of the latest treatments and methodologies. Utilising the immune system to beat cancer is becoming a best-practice method of treatment, but rapid upskilling is required to ensure excellent outcomes.

CTLA4 blocking antibodies are a novel immune checkpoint blockade therapy.

Please sign in to read more